 Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Retatrutide for Sale > China quality peptide Retatrutide 10mg 15mg 20mg 30mg 40mg 50mg 60mg 100mg lyophilized Bulk wholesale powder in stock,

China quality peptide Retatrutide 10mg 15mg 20mg 30mg 40mg 50mg 60mg 100mg lyophilized Bulk wholesale powder in stock, buy - large image1

China quality peptide Retatrutide 10mg 15mg 20mg 30mg 40mg 50mg 60mg 100mg lyophilized Bulk wholesale powder in stock, buy - image1

China quality peptide Retatrutide 10mg 15mg 20mg 30mg 40mg 50mg 60mg 100mg lyophilized Bulk wholesale powder in stock, buy - image2

China quality peptide Retatrutide 10mg 15mg 20mg 30mg 40mg 50mg 60mg 100mg lyophilized Bulk wholesale powder in stock, buy - image3

China quality peptide Retatrutide 10mg 15mg 20mg 30mg 40mg 50mg 60mg 100mg lyophilized Bulk wholesale powder in stock, buy - image4

China quality peptide Retatrutide 10mg 15mg 20mg 30mg 40mg 50mg 60mg 100mg lyophilized Bulk wholesale powder in stock,

6988 Inquiries

Unit Price:

$50-60/G FOB

Get Latest Price 

CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

guangzhou

Brand:

Packaging:

10mg/vial,10vials/box

Price valid (until):

2027-12-31

Contact Supplier

 Chat Now

Changsha Duole Technology Co., Ltd

Company Type:

Trader

Location:

China

Payment Terms:

TT against copy of documents,D/P,L/C,TT against B/L draft before shipment

Average Lead Time:

2 days

Qualification:

Main Products:

Tirzepatide,Retatrutide,Semaglutide,Cagrilintide,NAD+,Bacteriostatic wate

 Visit Store

Product Description
Seller Information
History Price
Inquiry History

Description

Product Detail

Name:Mary

Whatsapp:+86 152 2772 7503

Email Address:sales1@xttch.com

Retatrutide (LY3437943) acetate is a triple agonist peptide for the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R).

Retatrutide acetate inhibits human GCGR, GIPR, and GLP-1R with EC50 values of 5.79, 0.0643, and 0.775 nM, respectively. It exhibits activity on mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191, and 0.794 nM, respectively.

In vivo, Retatrutide (LY3437943) acetate engages with GCGR and enhances glucose tolerance in an ipGTT by acting through GIP or GLP-1 receptors. Activation via the glucagon receptor by Retatrutide acetate leads to significant weight reduction and increased energy expenditure. Retatrutide acetate can be utilized in research related to obesity.

Name	Retatrutide
CAS RN	2381089-83-2
Solubility	Dissolved in dimethyl sulfoxide
Storage condition	-20°C
EINECS	200-001-8

Appearance: Powder

Purity: >99% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: To be determined

Shelf Life: >2 years if stored properly

Drug Formulation: To be determined

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Shop Best price Lyophilized vials 30mg Tirzepatide, Semaglutide, Retatrutide-Detailed Image 1

Shop Best price Lyophilized vials 30mg Tirzepatide, Semaglutide, Retatrutide-Detailed Image 4

Company profile

Changsha Duole Technology Co., Ltd was established in 2020 with strong research and development capabilities and superb synthesis technology, as well as advanced quality control measures.

With synthetic biology platform technology as the core, it conducts innovative research and development, mainly engaged in the research and development of recombinantly expressed pharmaceutical peptides and proteins. Its products include innovative drugs, APIs, pharmaceutical and green synthetic industrial enzymes, functional peptides and protein products, etc.

Its core team is composed of technical experts in the fields of pharmaceutical engineering, fermentation engineering and protein engineering. The company has built a 3,300-square-meter recombinant drug research and development center in Shibei, Yuelu District, Changsha City. It has a complete pharmaceutical engineering, preparation and quality research system and talent team, and has built a GMP workshop to meet the international market API supply and CDMO services.

At present, our company has realized the industrialization of a variety of biosynthetic peptide products and has obtained cooperation orders from many well-known domestic and foreign pharmaceutical companies.

Shop Best price Lyophilized vials 30mg Tirzepatide, Semaglutide, Retatrutide-Detailed Image 7

Shop Best price Lyophilized vials 30mg Tirzepatide, Semaglutide, Retatrutide-Detailed Image 9

Why choose us

Our company has independent factories, mass production of pharmaceutical intermediates, organic intermediates and other raw materials, widely used in medicine, health care products, cosmetics, nutritional supplements, food additives and other fields.

Our company adheres to the business philosophy of integrity and cooperation. scientific innovation and service first.With absolute quality assurance as the purpose and perfect service system as the basis, our company provides efficient and satisfactory consulting services, sincerely welcomes your business inquiries,and looks forward to working with you to create a new future.

Key Products:
Our primary focus encompasses a range of products, including weight loss peptides, medicinal peptides, cosmetic peptides, and customized peptides. Notable among our weight loss peptide offerings are Semaglutide, Tirzepatide, Retatrutide, and others.

Certificates

ECHEMI Editorial Reference

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

Basic Info

Product Name:

Retatrutide

Other Name:

Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

CAS No.:

2381089-83-2

InChIKeys:

MLOLQJNKXBNWFW-SAGGEDDASA-N

Molecular Weight:

EC Number:

200-001-8

Color/Form:

White lyophilized

Categories:

Bulk Drug Intermediates

Characteristics

Water Solubility:

Soluble in water (5mg/ml).

Storage Conditions:

-20°C

Critical Temperature & Pressure:

-20°C

Research

Class:

Triple agonist — GCGR, GIPR, GLP-1R

Status:

Investigational (Phase 3)

Mechanism:

Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

EC50 (Human GCGR):

5.79 nM

EC50 (Mouse GIPR):

0.191 nM

EC50 (Mouse GLP1R):

0.794 nM

EC50 (Mouse GCGR):

2.32 nM

EC50 (Human GLP1R):

0.775 nM

EC50 (Human GIPR):

0.0643 nM

Source:

Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

Clinical Development:

NCT04881760; NCT05882045; NCT06354660

References

ChEMBL:

DrugBank:

KEGG DRUG:

PubChem:

Literature:

NEJM: Jastreboff et al. (2023) — Phase 2 Trial; FDA Drugs@FDA

Disclaimer:

Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

See More Retatrutide Properties 

Seller Information

Business Type:
Trader

Main Products:
Tirzepatide,Retatrutide,Semaglutide,Cagrilintide,NAD+,Bacteriostatic wate

Location:
Jinxing Middle Road, Xihu Street, Yuelu District, Changsha City, Hunan Province

Payment Terms:
TT against copy of documents,D/P,L/C,TT against B/L draft before shipment

Average lead Time:
2 days

Total Annual Revenue:
$1 million-$2.5 million

Total Employees:
11-50

Year of Establishment:
2023

Changsha Duole Technology Co., Ltd

Changsha Duole Technology Co., Ltd was established in 2020 with strong research and development capabilities and superb synthesis technology, as well as advanced quality control measures.

With synthetic biology platform technology as the core, it conducts innovative research and development, mainly engaged in the research and development of recombinantly expressed pharmaceutical peptides and proteins. Its products include innovative drugs, APIs, pharmaceutical and green synthetic industrial enzymes, functional peptides and protein products, etc.

Its core team is composed of technical experts in the fields of pharmaceutical engineering, fermentation engineering and protein engineering. The company has built a 3,300-square-meter recombinant drug research and development center in Shibei, Yuelu District, Changsha City. It has a complete pharmaceutical engineering, preparation and quality research system and talent team, and has built a GMP workshop to meet the international market API supply and CDMO services.

At present, our company has realized the industrialization of a variety of biosynthetic peptide products and has obtained cooperation orders from many well-known domestic and foreign pharmaceutical companies.
Weekly Price

 The chart shows the price trend of the product in the past 12 months.

Inquiry History

6988 Inquiries

Country	Product	Purchase Quantity	Date Posted
United States	Retatrutide 2381089-83-2	3 MT	Mar 28, 2026
United Kingdom	Retatrutide - 2381089-83-2	1 G	Feb 10, 2026
United States	Retatrutide CAS 2381089-83-2 10mg vial	20 MT	Mar 7, 2026
United States	Factory Retatrutide API 99% Purity CAS 2381089-83-2	5 KG	Nov 10, 2025
United Kingdom	Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA	1 MT	Mar 22, 2026
United States	2381089-83-2	100 G	Jul 14, 2026
United States	2381089-83-2	100 G	Feb 24, 2026
United States	2381089-83-2	100 MT	Dec 9, 2023
United States	Retatrutide 2381089-83-2	200 MG	May 16, 2026
United Kingdom	2381089-83-2 retatrutide	300 MG	Feb 13, 2026
United States	Retatrutide 2381089-83-2 wholesale	500 MT	Nov 3, 2023
United States	Retatrutide CAS 2381089-83-2 99%	10 PCS	Feb 21, 2026
Poland	CAS 2381089-83-2 (Custom Peptide)	40 MT	Apr 10, 2026
Austria	Peptide Retatruide CAS 2381089-83-2	100 MT	Apr 4, 2026
Austria	Retatrutide CAS 2381089-83-2 10mg vial	20 PCS	Feb 10, 2026
United States	GLP-1 / GIP Retatrutide cas 2381089-83-2	1 MT	Oct 16, 2024
United States	Retatrutide 99% High Quality CAS 2381089-83-2	1 G	Jan 23, 2026
United States	Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2	10	Oct 21, 2023
Australia	GMP Grade 99% Retatrutide Lyophilized Powder CAS 2381089-83-2	10 G	Jun 12, 2026
Palestine	Factory 99% Purity Retatrutide Peptide CAS 2381089-83-2 Door-To-Door Service	10 MG	Mar 16, 2026

Go to Page

Post an enquiry for this product

More Choices Find All Products for Sale 

Product Name	Grade / Content	Price	Supplier Name	Details
Retatrutide Raw Powder High Purity Hot Sale Weight Loss Peptide retatrutide CAS 2381089-83-2 10mg 20mg	Pharmaceutical Grade/99	$50/UNIT FOB	Ningbo Shu You plastic Co., LTD	Inquiry
Best Price and 99.9 High Purity Weight Loss Peptides Retatrutide 10mg 20mg 30mg/Vial Retatrutide CAS 2381089-83-2 30mg 40mg 60mg	Pharmaceutical Grade/99	$371/UNIT FOB	Hangzhou Zhongqing Trading Co., Ltd	Inquiry
US Warehouse \| GLP-1 Peptides Powder \| Retatrutide 10mg 15mg 20mg 30mg Vials \| Weight Loss, Appetite Suppression \| Chemical Reagent	Pharmaceutical Grade/99.9	$13-16/UNIT FOB	Runlian peptide supplier	Inquiry
Retatrutide \| US Warehouse \| GLP-1 GIP GCG Peptides \| 99.48% Purity \| 5mg 10mg 20mg 30mg Vials \| Lyophilized Powder	Pharmaceutical Grade/	$90-110/UNIT EXW	Hong Kong JuXing Biotechnology Co limited	Inquiry
RT40---------+-+High purity, large quantity, discounted price. Direct delivery from the manufacturer.	Pharmaceutical Grade/99.9	$1-1.3/MT FOB	Hong Kong Biopetide Research Limited	Inquiry

China quality peptide Retatrutide 10mg 15mg 20mg 30mg 40mg 50mg 60mg 100mg lyophilized Bulk wholesale powder in stock,

Product Description

Seller Information

History Price

Inquiry History

Name

Retatrutide

CAS RN

2381089-83-2

Solubility

Dissolved in dimethyl sulfoxide

Storage condition

-20°C

EINECS

200-001-8

More Choices Find All Products for Sale 

Related Searches

More from this Seller